Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kroeger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine Technology|August 1, 2012
NCOR reportMichael Kroeger
Heliyon|March 22, 2018
Viability Test Device for anisakid nematodesMichael Kroeger, Horst Karl, Bernhard Simmler, et al.
Urologic Oncology|July 31, 2017
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim resultsVignesh T Packiam, Donald L Lamm, Daniel A Barocas, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine Technology|August 1, 2012
NCOR reportMichael Kroeger
Heliyon|March 22, 2018
Viability Test Device for anisakid nematodesMichael Kroeger, Horst Karl, Bernhard Simmler, et al.
Urologic Oncology|July 31, 2017
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim resultsVignesh T Packiam, Donald L Lamm, Daniel A Barocas, et al.
Pageof 1